Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision stamp updated from v3.6.4 to v3.6.5, signaling a routine platform update. The study page content and visible information appear unchanged.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a minor page refresh rather than a change to study content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry appears, updating the platform version to v3.6.3 and removing the previous v3.6.2 from the revision history.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page displays Revision: v3.6.2, replacing the prior v3.6.0. This is a routine version update that does not modify the study details or what users see on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, plus a new revision tag (Revision: v3.6.0); older labels such as 'Verified' and 'Last known status was:' are removed.SummaryDifference1%

- Check67 days agoChange DetectedThe page's revision label was updated to v3.5.5, indicating a minor update to the entry rather than a change to study details.SummaryDifference0.1%

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.